Teaching is organised as follows: | |||
Activity | Credits | Period | Academic staff |
Malattie del sangue 4 - Krampera | 0.84 | not yet allocated |
Mauro Krampera
|
Malattie del sangue 4 - Tecchio | 0.66 | not yet allocated |
Cristina Tecchio
|
Malattie del sangue 4 - Bonifacio | 0.84 | not yet allocated |
Massimiliano Bonifacio
|
Malattie del sangue 4 - Visco | 0.66 | not yet allocated |
Carlo Visco
|
Analisi studi clinici ematologici sperimentali e linee guida | 0.5 | not yet allocated |
Ancora Da Definire
|
Immunoematologia e medicina trasfusionale | 0.5 | not yet allocated |
Sabrina Genesini
|
Trapianto allogenico di cellule staminali - Benedetti | 1 | not yet allocated |
Fabio Benedetti
|
Patologia dell'emostasi - Tosetto | 1 | not yet allocated |
Alberto Tosetto
|
Non-Hodgkin lymphomas are a group of neoplastic diseases caused by a monoclonal proliferation of lymphoid cells in various lymphoreticular sites, including the lymph nodes, bone marrow, spleen, liver and gastrointestinal tract. Among the most common symptoms at onset there is usually the presence of peripheral lymphadenopathy. However, in some patients non-Hodgkin lymphomas present without adenopathy, but with transformed lymphocytes in the circulation. The disease is likely to be disseminated at the time of onset, and the diagnosis is usually based on biopsy of the lymph node or bone marrow or both. Management strategies may include watch and wait, chemotherapy, targeted drugs (eg, kinase inhibitors), and immunotherapies (eg, monoclonal antibodies, chimeric antigen receptor T cells); occasionally, radiation therapy is added. With a few exceptions, stem cell transplant is usually reserved for patients with aggressive lymphomas following incomplete remission or relapse.
Oral, with learning assessment based on questions and answers and comments on the individual topic.
© 2002 - 2024
Verona University
Via dell'Artigliere 8, 37129 Verona |
P. I.V.A. 01541040232 |
C. FISCALE 93009870234